Puma Biotechnology (PBYI) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.
- Puma Biotechnology's Profit After Tax fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 5931.33%. This contributed to the annual value of $30.3 million for FY2024, which is 4033.63% up from last year.
- Latest data reveals that Puma Biotechnology reported Profit After Tax of $8.8 million as of Q3 2025, which was down 5647.0% from $5.9 million recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's Profit After Tax peaked at $20.3 million during Q3 2024, and registered a low of -$44.7 million during Q3 2021.
- For the 5-year period, Puma Biotechnology's Profit After Tax averaged around $2.1 million, with its median value being $3.0 million (2025).
- As far as peak fluctuations go, Puma Biotechnology's Profit After Tax skyrocketed by 171000.0% in 2023, and later plummeted by 44368.31% in 2024.
- Puma Biotechnology's Profit After Tax (Quarter) stood at $4.2 million in 2021, then tumbled by 232.72% to -$5.6 million in 2022, then soared by 318.84% to $12.3 million in 2023, then soared by 57.54% to $19.3 million in 2024, then tumbled by 54.24% to $8.8 million in 2025.
- Its last three reported values are $8.8 million in Q3 2025, $5.9 million for Q2 2025, and $3.0 million during Q1 2025.